Keri Schick Norton, P.C.

Private Equity Representation

• Altas Partners in its investment in Mercer Advisors
• Warburg Pincus in its investment in ParetoHealth
• Altas Partners in connection with Leonard Green Investment in Hub International Limited
• Altas Partners-backed Pye-Barker in its acquisition of Briscoe Protective from Novidam Capital Partners
• Carlyle Global Credit in its $3 billion acquisition of iStar’s net lease business
• The Carlyle Group in its acquisition of Jagex
• Warburg Pincus, together with Mubadala Investment Co., in its £1.9 billion acquisition of Pharma Intelligence from Informa
• Warburg Pincus-backed Citeline in its merger of equals with Norstella to form an end-to-end life sciences solutions provider
• Warburg Pincus-backed Newfi in its sale to Athene
• Warburg Pincus-backed Reorg in its sale to Permira
• Warburg Pincus-backed Sagent in its acquisition of certain intellectual property rights related to Mr. Cooper Group’s proprietary, cloud-based technology platform for mortgage servicing
• ABRY Partners in its $1.52 billion sale of Language Line Solutions
• Blackstone in its acquisition of SESAC Holdings, a leading music rights organization, from Rizvi Traverse Management
• Blackstone in its acquisition of Aon plc’s technology-enable benefits and HR platform
• Blackstone Tactical Opportunities in its investment in Diligent Corporation
• BRS & Co. in its sale of Simpson Performance Products
• Bruckmann, Rosser, Sherrill & Co. in its acquisition of 2nd Ave LLC and Greendrop
• A consortium led by CC Capital in its $6.9 billion acquisition of Dun & Bradstreet
• L Catterton Partners in its investment in Peloton Cycle
• L Catterton Partners in its acquisition of CorePower Yoga
• New Mountain Capital in its $600 million acquisition of TRC Companies, Inc.
• The Carlyle Group on its acquisition of Jagex
• The Jordan Company in its investment in Young Innovations, Inc.
• Warburg Pincus in its joint venture with Fiserv Inc. related to the carve out of Fiserv’s Lending Solutions business
• Warburg Pincus in its investment in Nexera Holding
• Warburg Pincus in its investment in Quantum Health
• Warburg Pincus in its investment in Samsara

Public Company Representation

• Eli Lilly in its $1.4 billion acquisition of POINT Biopharma
• Eli Lilly in its $610 million acquisition of Akouos
• Eli Lilly in its exclusive collaboration and equity investment in Lycia Therapeutics
• Accenture in its joint venture with Apax Partners relating to the carve out of Accenture’s Duck Creek Technologies and subsequent initial public offering
• Accenture in its acquisition of CreativeDrive
• Accenture in its acquisition of Clarity Insight
• Accenture in its acquisition of IBB Consulting
• Accenture in its acquisition of DayNine
• Accenture in its $830 million carveout sale of Navitaire to Amadeus IT SA
• Abbott in its $5.8 billion acquisition of Alere Inc.
• Bristol-Myers Squibb in its $90 billion acquisition of Celgene Corporation
• Covetrus on its $250 million equity investment by Clayton, Dubilier & Rice
• Marriott Vacations Worldwide in its $4.7 billion acquisition of ILG, Inc.
• WellCare Health Plans in its $17.3 billion acquisition by Centene Corporation
• WellCare Health Plans in its $2.5 billion acquisition of Meridian Health Plans
• WellCare Health Plans in its $800 million acquisition of Universal American Corp.